Unmet needs in the treatment of glioblastoma (Q48614301)

13 February 2018

editorial

0 references

title

Unmet needs in the treatment of glioblastoma (English)

1 reference

13 February 2018

author name string

Melike Mut

series ordinal

1

1 reference

13 February 2018

David Schiff

series ordinal

2

1 reference

13 February 2018

publication date

1 May 2009

1 reference

13 February 2018

Expert Review of Anticancer Therapy

published in

1 reference

13 February 2018

volume

9

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

545-551

1 reference

13 February 2018

Guidelines for the treatment of newly diagnosed glioblastoma: introduction.

cites work

1 reference

A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.

21 January 2018

1 reference

Incidence of central nervous system tumors in Gironde, France

21 January 2018

1 reference

Temporal trends in incidence of primary brain tumors in the United States, 1985-1999

21 January 2018

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

Patterns of care in elderly glioblastoma patients

21 January 2018

1 reference

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma

21 January 2018

1 reference

21 January 2018

1 reference

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

21 January 2018

Single Brain Metastasis

1 reference

T2 detection of tumor invasion within segmented components of glioblastoma multiforme

21 January 2018

1 reference

Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.

21 January 2018

1 reference

Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy.

21 January 2018

1 reference

Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy

21 January 2018

1 reference

Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status

21 January 2018

1 reference

21 January 2018

1 reference

The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

21 January 2018

1 reference

Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas

21 January 2018

1 reference

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

21 January 2018

1 reference

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults

21 January 2018

1 reference

Extent of resection as a prognostic variable in the treatment of gliomas

21 January 2018

1 reference

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

21 January 2018

1 reference

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

21 January 2018

1 reference

Intraoperative imaging in glioblastoma resection

21 January 2018

1 reference

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients

21 January 2018

1 reference

'Recurrent' glioblastoma multiforme, when should we reoperate?

21 January 2018

1 reference

Survival and functional status after resection of recurrent glioblastoma multiforme

21 January 2018

1 reference

Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery

21 January 2018

1 reference

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

Intracavitary chemotherapy (paclitaxel/carboplatin liquid crystalline cubic phases) for recurrent glioblastoma -- clinical observations

21 January 2018

1 reference

Photodynamic therapy of high grade glioma - long term survival.

21 January 2018

1 reference

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

21 January 2018

1 reference

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

21 January 2018

1 reference

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial

21 January 2018

1 reference

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

21 January 2018

1 reference

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

21 January 2018

1 reference

Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas

21 January 2018

1 reference

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide

21 January 2018

1 reference

Therapeutic options for recurrent high-grade glioma in adult patients: recent advances

21 January 2018

1 reference

A comparison of treatment results for recurrent malignant gliomas

21 January 2018

1 reference

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

21 January 2018

1 reference

Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme

21 January 2018

1 reference

A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma

21 January 2018

1 reference

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

21 January 2018

1 reference

Encountering and advancing through antiangiogenesis therapy for gliomas

21 January 2018

1 reference

Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database

21 January 2018

1 reference

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

21 January 2018

1 reference

Canadian recommendations for the treatment of glioblastoma multiforme.

21 January 2018

1 reference

Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors

21 January 2018

1 reference

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

21 January 2018

1 reference

Interactions between antiepileptic and chemotherapeutic drugs

21 January 2018

1 reference

Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?

21 January 2018

1 reference

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

21 January 2018

1 reference

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.09.24

1 reference

13 February 2018

1 reference

13 February 2018